Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| BDF-H5116 | Human | Human BDNF / Abrineurin Protein (E. coli), premium grade |  |
|
|
| BDF-H5219 | Human | Human BDNF / Abrineurin Protein (HEK293), premium grade |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Laquinimod Sodium | SAIK-MS; TV-5600; ABR-215062 | Approved | Active Biotech Ab | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Huntington Disease; Eye Diseases; Arthritis; Uveitis; Crohn Disease | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Tetramethylpyrazine Nitrone | Phase 3 Clinical | Jinan University | Diabetes Mellitus, Type 2; Stroke; Diabetic Nephropathies; Amyotrophic Lateral Sclerosis | Details | |
| ACT-01 | ACT-01; OCS-05; BN-201; G-79 | Phase 2 Clinical | Promius Pharma | Keratosis, Actinic; Optic Neuritis; Demyelinating Diseases | Details |
| MP-101 | MP101; MP-101 | Phase 2 Clinical | Mitochon Pharmaceuticals | Multiple Sclerosis; Huntington Disease; Amyotrophic Lateral Sclerosis | Details |
| ALTO-100 | ALTO-100 | Phase 2 Clinical | Alto Neuroscience Inc | Depressive Disorder, Major; Bipolar I Disorder; Stress Disorders, Post-Traumatic; Bipolar II Disorder | Details |
| AC-102 | AC-102 | Phase 2 Clinical | AudioCure Pharma GmbH | Tinnitus; Hearing Loss, Sensorineural; Hearing Loss, Sudden | Details |
| TTI-0102 | TTI-0102 | Phase 2 Clinical | Va Office Of Research And Development | MELAS Syndrome; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Stress Disorders, Post-Traumatic | Details |
| JS1-1-01 | JS1-1-01 | Phase 2 Clinical | Tianjin Tasly Pharmaceutical Co Ltd | Depression; Depressive Disorder, Major; Depressive Disorder | Details |
| AAV2-BDNF gene therapy (University Of California San Diego) | Phase 1 Clinical | University Of California San Diego | Alzheimer Disease; Cognitive Dysfunction | Details |
This web search service is supported by Google Inc.
A-Z
